This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heartfailure monitoring detected twice as many heartfailure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heartfailure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: HeartFailure. Heartfailure (HF) is a leading cause of hospitalization in the United States.
The clinical role and educational preparation of heartfailure nurses across Europe. HF, heartfailure; HFN, heartfailure nurse; MDT, multidisciplinary team. A total of 837 nurses involved in the daily care of patients with HF from 15 countries completed the survey.
Our findings represent a significant advancement in clinical practice that can ultimately enhance patientcare." The study used 6,000 heart sound recordings paired with echocardiographic pressure estimates to train the AI model.
Kittleson, director of HeartFailure Research and director of Post Graduate Medical Education in HeartFailure and Transplantation, is an associate editor specializing in heartfailure. She also has served on the board of directors of the HeartFailure Society of America.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
Heartfailure (HF) is a prevalent and complex condition that demands precise and efficient management. This paper delves into a critical, yet often under-recognised, challenge in HF care – the accurate coding of patients on HF registers.
Atrial fibrillation (AF) significantly increases the risk of stroke and heartfailure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Early detection in selected patients may aid in stroke prevention and mitigate structural heart complications through prompt intervention.
mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patientcare through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heartfailure, and other complex cardiac conditions. An expert in diagnosing heartfailure, Kobashigawa also is director of the Advanced Heart Disease Division in the Smidt Heart Institute.
Introduction:It is estimated that about 30% of patients with heartfailure (HF) have iron deficiency anemia that can be masked as chronic normocytic anemia or functional anemia. Currently, the ACC/AHA 2022 heartfailure guidelines give IV Iron replacement a Class IIa recommendation. However, only 18.8%
HF patients commonly face periods of stability interrupted by episodes of worsening symptoms and volume retention which causes physicians to put them on diuresis. Due to financial incentives and patient preference, oral diuretics tend to be more popular than intravenous loop diuretics because they dont require in-patientcare.
The recent British Society for HeartFailure (BSH) 27 th hybrid annual meeting highlighted the importance of building partnerships with collaborating societies and how this is vital to prioritising patientcare and advancing the goal of 25in25, the BSH campaign to reduce heartfailure mortality by 25% over the next 25 years.
By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. In fact, approximately1 in 8 health care dollarsis spent on cardiovascular disease.
In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heartfailure, coronary artery disease, vascular disease and atrial fibrillation.
Anumana’s software-as-a-medical device (SaMD) ECG-AITM solutions aim to detect hidden diseases using standard-of-care ECG readings, enabling clinicians to enhance and improve care with real-time AI insights. Food and Drug Administration ( FDA ) clearance in September 2023, and is currently under review in Europe.
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heartfailure.
The proposed independent Board of Cardiovascular Medicine, governed by cardiologists for cardiologists, would facilitate a deep understanding of competencies to ensure high-value cardiovascular patientcare.
Reprieve Cardiovascular emerged this week , announcing a hefty $42M Series A round and an even bigger mission to “transform the standard of care” for patients with acute decompensated heartfailure.
Here is an overview of sessions, events and meetings coordinated to help members in particular specialties, sections and areas of interest learn and engage with peers and expert cardiology professionals to advance their practice, patientcare and careers. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24”
Left untreated, tricuspid regurgitation can lead to atrial fibrillation , heartfailure , kidney disease and even death. The UC Davis Structural Heart Team is among the best and most comprehensive in the nation. Rogers , professor of cardiovascular medicine.
All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heartfailure, and hypertension requires the ability to monitor a heart’s condition. In response, an increasing number of clinics have chosen to rely on cardiac remote patient monitoring ( RPM ) software.
“By pioneering a user-friendly device that enables frequent 12-lead ECGs over time and by coupling AI with our proprietary VECG technology that can go beyond a 12-lead ECG, HeartBeam is well-positioned to identify nuanced cardiac trends that could ultimately improve patientcare.”
For patients, this means consistent image interpretation which can lead to fewer re-scans, shorter and more effective interventional procedures, and potentially faster recovery times.” Heartfailure is a rapidly growing health issue that affects an estimated 64 million people worldwide 1.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 More information: www.acc.org If you enjoy this content, please share it with a colleague
During the event, to take place at the Signia by Hilton Atlanta, innovators will gather in one room throughout the conference, gaining insights into regulatory approvals, clinical trials, market adoption, and the integration of novel technologies into patientcare.
Mohr-Durdez added, “To help enhance patientcare in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analyzing cardiac electrical signals.” 1 Approximately 33 million patients worldwide are living with AFib.
Circulation: HeartFailure, Ahead of Print. BACKGROUND:Cardiac allograft rejection is the leading cause of early graft failure and is a major focus of postheart transplant patientcare.
This control and access to comprehensive data instill confidence in delivering personalized care. With the rise of digital health tools and the integration of AI in cardiology, the patientcare landscape is becoming more data-driven, making it essential for systems to operate harmoniously.
These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes. This blog explores the profound benefits of AI and machine learning, which are revolutionizing cardiology practices, enhancing efficiency, and ultimately improving patientcare.
Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patientcare worldwide." For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heart disease at TVT.
Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patientcare worldwide." For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heart disease at TVT.
Implementation of this dataset will facilitate global standardization of outcome measurements and allow for meaningful comparison between health care systems, evaluation of clinical practice guidelines, and improvement of patientcare for people experiencing heart valve disease worldwide.
What’s more, an increasing shortage of resources – physicians, as well as nurses – is escalating the vast backlog of cardiac care. As we all know, early diagnosis of such diseases is crucial in order to prevent patients from suffering heartfailure or sudden death. This is why time is so important.
heartfailure). The Takeaway Cardiology faces its share of challenges, but AHA 2023 made it clear that plenty of solutions are on the horizon, and some of the smartest and most passionate people in medicine are ready to bring these solutions into patientcare.
The Role of Cardiologists Cardiologists are at the forefront of the battle against heart diseases. Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heartfailure, arrhythmias, and congenital heart defects.
Compared to the reference group, patients with AIS alone and patients with concurrent CAD and AIS had higher MI risk (hazard ratio [HR] 4.91, 95% CI 4.63-5.21, 2.73, P = 0.04, respectively), while patients with CAD alone had no elevated risk (HR 1.17, 95% CI 0.66-2.06, 5.21, P < 0.001; HR 1.67, 95% CI 1.02-2.73,
Available as software with service or a software-only solution, clinics and their patients are invited to try The Vector PatientCare Platform™. Let’s discuss how the future of cardiac remote patient monitoring can help improve your clinic.
The patient advised overall improvement with complete resolution of symptoms. The patientcare narrative states no further changes in heart rate with persistent LBBB morphology. LBBB may be the precipitating cause of the heartfailure syndrome, or may portend high mortality when identified in preexisting heartfailure.
Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patientcare and outcomes.
I was then asked to go over to the University of Washington to one of their main teaching hospitals to start a heartfailure program, which I did, and then got roped again into a lot of administrative things, and so quickly became chief of cardiology, and started this and started that.
One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patientcare and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.
These devices are implanted under the skin and can monitor the heart’s rhythm, delivering as-needed electrical shocks to correct abnormal heart rhythms. Specialized pacemakers used to treat heartfailure, monitor heart rhythm and adjust pacing as needed. Cardiac Resynchronization Therapy (CRT) Devices.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content